drugset / Trial / NCT07162441
A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers
Non-randomizedCrossoverOpen-labelTreatment
Summary
This study is open-label, multiple-dose, two-intervention group, single-sequence, crossover design to compare the safety and pharmacokinetics of UIC202502 and UIC202505 when administered alone or in combination.
Timeline
- Start
- 2025-08-12
- Primary completion
- 2025-09-30
- Completion
- 2026-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | UIC202502 | Unknown | 1 unknown | — |
| Subject | UIC202505 | Unknown | 1 unknown | — |